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TenA (transcriptional enhancer A) has been proposed to
function as a transcriptional regulator based on observed
changes in gene-expression patterns when overexpressed in
Bacillus subtilis. However, studies of the distribution of
proteins involved in thiamine biosynthesis in different fully
sequenced genomes have suggested that TenA may be an
enzyme involved in thiamine biosynthesis, with a function
related to that of the ThiC protein. The crystal structure of
PF1337, the TenA homolog from Pyrococcus furiosus, is
presented here. The protomer comprises a bundle of -helices
with a similar tertiary structure and topology to that of human
heme oxygenase-1, even though there is no significant
sequence homology. A solvent-sequestered cavity lined by
phylogenetically conserved residues is found at the core of this
bundle in PF1337 and this cavity is observed to contain
electron density for 4-amino-5-hydroxymethyl-2-methyl-
pyrimidine phosphate, the product of the ThiC enzyme. In
contrast, the modestly acidic surface of PF1337 shows minimal
levels of sequence conservation and a dearth of the basic
residues that are typically involved in DNA binding in
transcription factors. Without significant conservation of its
surface properties, TenA is unlikely to mediate functionally
important protein–protein or protein–DNA interactions.
Therefore, the crystal structure of PF1337 supports the
hypothesis that TenA homologs have an indirect effect in
altering gene-expression patterns and function instead as
enzymes involved in thiamine metabolism.
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1. Introduction
The tenA locus was initially identified in a screen (Pang et al.,
1991) for Bacillus subtilis genes whose expression produces
strong pleiotropic increases in the yield of secreted enzymes
(Priest, 1977). Because this effect was shown to be associated
with increased transcription of the genes encoding these
extracellular enzymes, the locus was named ‘transcriptional
enhancer A’ or tenA, and it was hypothesized that the TenA
protein product might function as a transcriptional regulatory
factor. If this hypothesis is correct, TenAwould provide a very
rare example of a transcription factor that functions in all
three kingdoms of life, as homologous domains are found in
proteins in eubacteria, archaebacteria and eukaryotes (Pang et
al., 1991).
However, studies of gene distribution in fully sequenced
genomes have suggested that TenA may instead function as an
enzyme involved in thiamine (vitamin B1) biosynthesis. This
cofactor is an essential nutrient for mammals, in which a
nutritional deficiency causes the disease beriberi, but it is
synthesized de novo by many microorganisms including
Escherichia coli, Salmonella typhimurium, Bacillus subtilis and
Saccharomyces cerevisiae. Thiamine pyrophosphate (THI-
PP), the active form of this cofactor, has well characterized
enzymatic functions in carbohydrate metabolism and more
generally in stabilizing acyl carbanions in metabolic transfor-
mations (Schowen, 1998).
While more than 30 years of genetic, enzymological (Begley
et al., 1999; Hohmann & Meacock, 1998) and structural (Chiu
et al., 1999; Settembre et al., 2003) research on thiamine
biosynthesis has revealed a plethora of novel chemistry, some
catalytic steps are not clearly understood. The thiamine-
biosynthesis pathway is divided into two branches directing
the synthesis of the two main building blocks of the molecule,
the thiazole and pyrimidine moieties. In E. coli, the active
form of thiamine or thiamine-pyrophosphate is obtained by
phosphorylation of thiamine-phosphate by the kinase ThiL.
Thiamine phosphate is assembled by ThiE (thiamine
phosphate synthase) using two substrates: 4-methyl-5-(-
hydroxyethyl)thiazole phosphate and 4-amino-5-hydroxy-
methyl-2-methylpyrimidine-pyrophosphate (HMP-PP). The
first of these precursors can be synthesized either through
phosphorylation of 4-methyl-5-(-hydroxyethyl)thiazole by
the ThiM kinase or through a complex but well established
reaction catalyzed by six enzymes (dxs, ThiF, ThiG, ThiI, ThiH
and ThiS) employing glyceraldehyde-3-phosphate, pyruvate,
cysteine and ATP as substrates (Begley et al., 1999). The
second precursor (HMP-PP) is synthesized through phos-
phorylation of 4-amino-5-hydroxymethyl-2-methylpyrimidine
phosphate (HMP-P) by the ThiD kinase. HMP-P itself can be
synthesized either through phosphorylation of 4-amino-
5-hydroxymethyl-2-methylpyrimidine (HMP) by ThiD or
alternatively through a poorly understood reaction catalyzed
by the ThiC enzyme using 50-phosphoribosyl-5-aminoimida-
zole (AIR) as a substrate. Although isotopic tracer experi-
ments establish AIR as the substrate for HMP synthesis in
bacterial extracts, it has not yet been possible to reconstitute
this reaction in vitro using purified enzymes (Cheng et al.,
2002; Estramareix & David, 1990; Himmeldirk et al., 1998;
Begley et al., 1999), indicating that it involves kinetic or
mechanistic complexities that have yet to be elucidated.
Analysis of the gene content of a series of fully sequenced
microbial genomes revealed that some of the well character-
ized enzymes in the pathway are missing in some organisms
capable of de novo thiamine biosynthesis (Morett et al., 2003),
suggesting that alternative enzymes may function to mediate
some catalytic steps. In this context, it was intriguing that the
TenA protein is transcribed as part of an operon involved in
thiamine biosynthesis in many organisms, including B. subtilis.
Moreover, this protein domain is found in a translational
fusion in the Thi-4 protein from Neurospora crassa (Akiyama
& Nakashima, 1996), where the second domain in the covalent
fusion is the ThiD kinase. Finally, studies of genomic organi-
zation (Rodionov et al., 2002; Morett et al., 2003) revealed that
the tenA gene occurs in different organisms in a largely
mutually exclusive manner with the thiC gene (which encodes
the ThiC enzyme). Subsequent studies showed that the
YCR020c (PET18) TenA homologue from yeast could
genetically complement a thiC deletion in E. coli, supporting
the hypothesis that the TenA protein may be an enzyme
directly involved in de novo thiamine biosynthesis with a
function related to that of ThiC, despite the absence of
sequence homology between these proteins (Morett et al.,
2003).
In this paper, we report the crystal structure of the PF1337
protein from Pyrococcus furiosus, which is target PfR34 of the
Northeast Structural Genomics Consortium. While the surface
of this TenA ortholog lacks the basic regions characteristic of
transcription factors that bind DNA, a solvent-sequestered
cavity is found in the core of the protomer containing
electron density for 4-amino-5-hydroxymethyl-2-methyl-
pyrimidine phosphate (HMP-P), an intermediate in the
thiamine-biosynthesis pathway that is the product of ThiC.
Therefore, the crystal structure of TenA strongly supports an
enzymatic function in thiamine biosynthesis and casts doubt
upon the hypothesis that it directly functions as a transcription
factor. These results demonstrate the utility of protein struc-
ture determination in clarifying biological and enzymatic
function, which represents a major goal of contemporary
genomic biology.
2. Materials and methods
2.1. Protein expression, purification and crystallization
Selenomethionine-labeled full-length PF1337 was
expressed and purified with an eight-residue C-terminal affi-
nity tag (LEHHHHHH) using previously described methods
(Benach et al., 2003). In brief, a pET21d (Novagen) derivative
was used for T7 expression in E. coli BL21(DE3) cells
containing a rare tRNA expression plasmid, and the protein
was purified using nickel-affinity and gel-filtration chromato-
graphy prior to concentration to 8 mg ml1 in 10 mM Tris,
100 mM NaCl and 5 mM DTT pH 8.0. Sample purity (>97%)
and molecular weight (25.7 kDa) were verified by SDS–PAGE
and matrix-assisted laser desorption ionization time-of-flight
mass spectroscopy (MALDI–TOF), respectively. Ortho-
rhombic plate-shaped crystals grew at 277 K in 3 d to
dimensions of 50  100  400 mm in 1 + 1 ml hanging-drop
vapor-diffusion reactions over a reservoir containing 20%
PEG 400, 200 mM CaCl2, 1 mM DTT, 50 mM cacodylate pH
7.5. Crystals were frozen in liquid propane using an additional
10% PEG 400. Owing to the limited commercial availability
of HMP(-P) compounds, attempts to co-crystallize with
HMP(-P) were not attempted.
2.2. X-ray data collection and structure determination
Multi-wavelength anomalous diffraction data were
collected from a single crystal at the selenium edge on a
Brandeis B4 detector on beamline X12C at the National
Synchrotron Light Source in consecutive 370 sweeps at
0.9790 A˚ (peak), 0.9794 A˚ (edge) and 0.9500 A˚ (remote) using
1, 30 s oscillations. Data were processed using DENZO and
SCALEPACK (Otwinowski & Minor, 1997). For each data
set, the scaling B factors of the final frames were within 3 A˚2 of
the initial frames, indicating that there was minimal decay
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during data collection. SOLVE (Terwilliger & Berendzen,
1999) identified 17 of the 20 Se atoms in the tetramer in the
asymmetric unit, yielding a map that was used for non-
crystallographic symmetry (NCS) averaging, density modifi-
cation (with 48% solvent content) and automated iterative
model building in AUTO_RESOLVE (Terwilliger &
Berendzen, 1999; Murshudov et al., 1997). This program
identified 71% of the backbone and 64% of the side chains in
the final model and produced a map that enabled 97% of the
structure to be built by hand using O (Jones et al., 1991).
Refinement in CNS (Bru¨nger et al., 1998) was conducted as
previously described (Benach et al., 2003) using standard
geometric and van der Waals restraints (Engh & Huber, 1991)
and was monitored by a randomly selected Rfree set containing
5% of the reflections. B factors were refined using standard
vicinal restraints (1.5–2.0 A˚2 for main-chain atoms and 2.0–
2.5 A˚2 for side-chain atoms). Strong NCS restraints
(1050 kJ A˚2, B = 1.5) were initially maintained throughout
the model but ultimately were released competely to produce
a considerable improvement in Rfree. The final model
contained residues 1–209 in molecule B (i.e. the entire protein
excluding the tag), residues 1–208 in molecule C and residues
1–206 in molecules A and D. Water-molecule sites were
selected automatically using CNS and checked for consistency
with 2Fo Fc electron-density and hydrogen-bonding criteria.
2.3. HPLC analysis of protein-bound small molecules
50 mg protein from the crystallization stock was lyophilized
after dialysis against 1 mM imidazole pH 7.0 and then
dissolved in 90% formic acid prior to injection onto a Vydac
C18 column (5 mm particles, 1.0 mm internal diameter,
150 mm length) running at 1 ml min1 in 1% acetonitrile
(AcN), 0.1% formic acid. A linear gradient to 80% AcN, 0.1%
formic acid was run after a 2 min isocratic elution. A
compound with a pyrimidine-like absorbance around 260 nm
eluted just before the start of the gradient in the protein
sample but not in a matched sample prepared from an equal
volume of dialysis buffer (data not shown).
3. Results and discussion
3.1. The crystal structure of PF1337
The PF1337 protein from P. furiosus shows 23% identity
and 48% similarity to the TenA protein from B. subtilis. Some
kind of orthologous relationship between these proteins is
supported by this sequence homology combined with the fact
that the pf1337 gene is located in a thiamine-biosynthesis
operon in P. furiosus and the fact that the genome of this
organism does not encode any other proteins with significant
homology to TenA. The crystal structure of PF1337 was solved
using multiwavelength anomalous diffraction (MAD) from
selenomethionine-labeled protein and refined to Rwork = 0.24
and Rfree = 0.28 at 2.35 A˚ resolution (Table 1). The secondary
structure of the protomer is entirely -helical (Figs. 1a and 1b).
Its core comprises a six-helix bundle surrounding a central
cavity that contains strong electron density in one protomer
consistent with the presence of HMP-P. (See below for a
discussion of ligand identification.) There are three short
-helices at the N-terminus of the protomer that pack onto
one surface of the helical bundle forming the core. Further-
more, one of the -helical segments forming the core contains
a short disruption that breaks it into two separate -helices
according to standard secondary-structure assignment
programs (8 and 9 in Fig. 1a), so that the structure contains
a total of ten -helices. Three of the five connections between
the helices forming the six-helix bundle are non-local (i.e.
between helices that are not at adjacent positions in the
bundle), giving the bundle a relatively complex topology
(Fig. 1b) involving both parallel and antiparallel -helix
packing (Fig. 1a).
The asymmetric unit of the crystal contains a tetramer of
PF1337 (Fig. 1c) with 222 symmetry (i.e. with three orthogonal
twofold axes) that buries 3528 A˚2 of solvent-accessible surface
area per protomer as calculated by CNS (Bru¨nger et al., 1998).
This oligomer is likely to be physiological based on the fact
that gel filtration and static light-scattering indicate PF1337 to
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Table 1
P. furiosus PF1337 data-collection and refinement statistics.
Standard definitions were used for all parameters (Drenth, 1994). Values in
parentheses are for the limiting resolution shell (2.43–2.35 A˚). The data-
reduction statistics are from SCALEPACK (Otwinowski & Minor, 1997) and
the refinement statistics from CNS (Bru¨nger et al., 1998). HMP-P is an
abbreviation for 4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate.
Crystal parameters
Space group P21212
Unit-cell parameters (A˚) at 100 K a = 101.8, b = 123.6,
c = 77.5
Data quality
Resolution range (A˚) 20.0–2.35
No. of measured reflections 239958 (22349)
No. of unique reflections 73637 (6861)
Rsym [I  3(I)] 0.07 (0.33)
Mean I/(I) [I  (I) after merging] 18.7 (6.6)
Mean redundancy 3.3 (3.3)
Completeness (%)
Measured reflections 93.5 (89.7)
I  2(I) (%) 74.8 (51.8)
Refinement residuals [F  (F)]
Rfree 0.28 (0.31)
Rwork 0.24 (0.27)
Model quality
R.m.s.d. bond lengths (A˚) 0.007
R.m.s.d. bond angles () 1.1
Average B factors (A˚2)
All 32.6
Main chain 30.3
Side chain 34.4
Average B factor for waters (A˚2) 34.2
R.m.s.d. B factors for nonbonded contacts (A˚2)
Main chain 4.9
Side chain 9.2
Ramachandran plot (%)
Core 96.1
Additional allowed 3.9
Model contents
No. of protein atoms 7089
No. of HMP-P atoms 14
No. of phosphate atoms 15
No. of water molecules 234
Protein residues 206 + 209 + 208 + 206
HMP-P molecules 1
Phosphate molecules 3
be tetrameric in solution (see supplementary material).1
Furthermore, a similar tetramer is found in the structure of
PH1161, the TenA ortholog from P. horikoshii (PDB code
1udd; Itou et al., 2004). One of the twofold axes in the tetramer
involves a tight dimer interaction in which 1600 A˚2 per
protomer is buried in a reciprocal packing interface between
helices 4 and 5 in subunits A and B (or C and D). The
second twofold axis buries 1159 A˚2 per protomer in a reci-
procal packing interaction between helix 6 in subunits A and
D (or B and C), while the third buries 963 A˚2 per protomer in
a reciprocal packing interaction between the loops connecting
helices 4–5, 6–7 and 9–10 in subunits A and C (or B and
D). Superimposing the individual monomers in the tetramer
gives r.m.s.d.s for C atoms of 0.21–0.30 A˚, with the largest
differences observed in the loops between
helices 3–4, 5–6 and 7–8. The 222
symmetry is most exact between the AB/
DC dimers (179.8) and least exact between
the AC/BD dimers (178.4).
3.2. Similarity of the PF1337 fold to known
structures
A search for structures similar to PF1337
was conducted using the program DALI,
which identified numerous domains with
similar tertiary structure. Most of these
bind heme or an iron ion and function in
mediating redox reactions. The closest
similarity to a protein that is not likely to be
orthologous to TenA is to human heme
oxygenase-1 (PDB code 1n45; Schuller et
al., 1999), which gives a Z score of 16.4 and
an r.m.s.d. of 3.1 A˚ for the alignment of the
C atoms in 189 residues sharing 14%
sequence identity (Fig. 2a). This protein has
identical topology to PF1337 and catalyzes
the NADPH-dependent oxidation of a
heme molecule that is sandwiched between
its amino-terminal -helix and the helical
bundle forming its core (Fig. 2a). Strong
structural similarity is also observed to the
R2 subunit of ribonucleotide reductase
(PDB code 1r2f; Logan et al., 1996; Z score
of 11.2 for alignment of 174 C atoms with
3.1 A˚ r.m.s.d. and 12% sequence identity)
and to methane monooxygenase hydro-
xylase (PDB code 1mhy; Elango et al., 1997;
Z score of 10.5 for alignment of 171 C
atoms with 3.1 A˚ r.m.s.d. and 12% sequence
identity). While these proteins have a
different topology to PF1337, they both
bind redox-active di-iron ions at a site
coincident with the cavity containing
HMP-P in PF1337 (e.g. as shown in Fig. 2b).
While we find no evidence for the presence
of iron ion or an iron-binding motif in
PF1337, the shared architecture could
reflect the ability of this protein fold to
provide a completely sequestered active
site to protect solvent-sensitive enzymatic
intermediates.
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Figure 1
Crystal structure of PF1337. (a) Stereo ribbon diagram (Carson, 1987) of PF1337 with a CPK
representation of HMP-P (oxygen, red; nitrogen, blue; carbon, gray; phosphorus, green). (b)
Topology diagram of PF1337. Red circles represent -helices, oriented perpendicular to the
plane of the page, with connections above the plane penetrating into the center of the circle and
those below stopping at the boundary. (c) Stereo ribbon diagram of the PF1337 tetramer with
CPK representations of HMP-P (magenta, subunit A) and inorganic phosphate (blue, subunits
B–D). The different subunits are colored in cyan (A), red (B), yellow (C) and green (D).
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: SX5026). Services for accessing these data are described at the
back of the journal.
3.3. Sequence-conservation patterns suggests that PF1337 is
an enzyme
The surface of PF1337 is mildly acidic (second row in
Fig. 3a), while that of DNA-binding transcription factors is
generally basic (Kim et al., 1993), and the relatively sparse
basic residues on the surface of PF1337 are not phylogeneti-
cally conserved (second and third rows of Fig. 3a and Fig. 4).
Moreover, PF1337 shows minimal levels of phylogenetic
conservation of any of its solvent-exposed surface residues
(third row of Fig. 3a). The highest sequence conservation on
the surface of the protomer occurs in the intersubunit inter-
faces of the tetramer, but even the most strongly conserved of
these sites (Ser114) has an identical residue in only 65% of the
homologs. In the non-interface region, there is one partially
exposed residue that is very strongly conserved (His20), but
the side chain of this residue forms a partially buried salt
bridge. The very low level of sequence conservation among
the solvent-exposed residues in PF1337 is contrary to the
pattern observed in proteins that bind macromolecular part-
ners such as protein or DNA (e.g. as shown in Figs. 3b and 3c;
Kim et al., 1993; Bahadur et al., 2004; Halperin et al., 2004,
Fernandez-Recio et al., 2004). In contrast, residues in the core
of PF1337 are very strongly conserved (fourth row of Fig. 3a).
In particular, many of the acidic and aromatic residues lining
the 330 A˚3 cavity that putatively binds HMP-P are nearly
invariant in all TenA homologs (fourth row of Fig. 3a and
Figs. 4 and 5b). Therefore, the pattern of sequence conserva-
tion in PF1337 is consistent with function as an enzyme with
specificity for HMP-P and contrary to expectations for a
protein that functions as a transcriptional regulator mediating
either protein–protein or protein–DNA interactions.
While many transcription factors are known to bind small-
molecule cofactors, these proteins show a
high level of phylogenetic conservation in
their surface residues just like other proteins
involved in mediating protein–protein or
protein–DNA interactions (Bahadur et al.,
2004; Halperin et al., 2004; Fernandez-Recio
et al., 2004). Two specific examples of the
surface-sequence conservation in ligand-
dependent transcription factors are shown
in Figs. 3(b) and 3(c). The NAD(P)(H)-
dependent NmrA protein from Aspergillus
nidulans regulates transcription via inter-
actions with the AreE protein (Stammers et
al., 2001) and the protein–protein inter-
action interfaces of NmrA show strong
phylogenetic conservation (Fig. 3b). The
cAMP-dependent CAP protein binds both a
specific DNA sequence and the C-terminal
domain of RNA polymerase (Schultz et al.,
1991; Benoff et al., 2002) and its surfaces
forming either the protein- or DNA-binding
sites exhibit similarly strong phylogenetic
conservation (Fig. 3c). No comparable
pattern of sequence conservation is
observed anywhere on the surface of
PF1337 when analyzed using the same
methods (third row in Fig. 3a), and this
inconsistency with the observed properties
of other transcription factors makes it un-
likely that TenA functions in this capacity.
3.4. Modeling of an HMP-P molecule in the
putative active site
Following completion of the refinement
of the PF1337 protein structure, strong
residual electron density was visible in the
cavity lined by phylogenetically conserved
residues at the core of the protomer
(Figs. 5a, 5b and 5c). This density was
consistent with the presence of a molecule
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Figure 2
Comparison to similar structures. Stereo diagrams showing superposition of PF1337 (yellow)
and structural homologs (blue). (a) shows human heme oxygenase (PDB code 1n45, with heme
ligand), while (b) shows E. coli ribonucleoside-diphosphate reductase 1 -chain (PDB code
1xik, with di-iron ligands). Bound ligands are shown in CPK representations colored like the
protein backbone (with HMP-P in PF1337). Figures were produced with DINO (http://
www.dino3d.org) and rendered with POVRAY (http://www.povray.org).
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Figure 3
Four views of the surface properties of PF1337, E. coli CAP and A. nidulans NmrA. (a) Four views of the PF1337 protomer showing the accessible
surface (Nicholls et al., 1991) colored by electrostatic potential (second row, with red or blue indicating potentials at 100 mM salt of 5kT or +5kT,
respectively) or sequence conservation [third row, with maroon indicating 100% conservation and white indicating no conservation among the sequences
in the COG (cluster of orthologous groups; Tatusov et al., 1997) according to the CONSURF algorithm (Glaser et al., 2003)]. The fourth row presents cut-
away views of a CPK model of the core of the protomer showing sequence conservation (analyzed and colored in the same manner as for the third row).
For reference, the first row shows ribbon diagrams of the protomer colored as in Fig. 1(a). (b) CONSURF analysis ofA. nidulansNmrA (PDB code 1k6x)
showing the regions that bind NAD(P)(H) and AreA. (c) CONSURF analysis of catabolite gene activator protein (CAP) from E. coli complexed with
DNA (PDB code 1cgp).
of HMP-P in subunit A and inorganic
phosphate molecules in the other
subunits. We excluded the presence of
an Fe iron or a cacodylate molecule
based on the absence of peaks in
anomalous difference Fourier maps
(data not shown). The correct identifi-
cation and high occupancy of the HMP-
P ligand is supported by several factors,
including low residual electron density
and good molecular geometry in the
ligand after refinement and the proxi-
mity of its B factors to those of the
adjacent protein side chains (with a
mean of 37 A˚2 for HMP-P compared
with 20 A˚2 for neighboring atoms).
Furthermore, acid extracts of the
protein in the crystallization stock
confirmed the presence of a pyrimidine
(see x2.2).
The HMP-P makes numerous
contacts to strongly conserved protein
residues (Figs. 5a and 5c). The pyrimi-
dine ring is sandwiched between the
aromatic side chains of Tyr132 and
Phe46, and the methyl group at position
2 makes van der Waals contacts to the
side chain of Phe201. Moreover, there
are numerous protein–ligand hydrogen
bonds, including ones with heteroatom
distances of 3.1 A˚ to all the N atoms
of HMP-P (Fig. 5c). Interestingly, the
hydrogen bonds between the side chain
of Asp43 and the N4 and amino groups
of the ligand mimic those observed in
HMP-P kinase (Cheng et al., 2002).
Glu79, Glu128 and Glu129 all make
hydrogen bonds to the phosphate in the
ligand. The fact that the most highly
conserved amino acids in this putative
active site are clustered around the
pyrimidine moiety in HMP-P (Fig. 5c)
suggests that PF1337 and other TenA
homologs may catalyze the formation
or chemical modification of the pyrimi-
dine ring, as previously proposed for
ThiC (Cheng et al., 2002; Estramareix &
David, 1990; Himmeldirk et al., 1998;
Begley et al., 1999). Interestingly, the
residues ligating the phosphate moiety
of HMP-P are substantially less
conserved, with the exception of Glu79
(which occurs in 80% of the likely
orthologs; Figs. 4 and 5c).
This observation suggests that
different TenA homologues might have
specificity for different compounds
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Figure 4
Phylogenetic conservation in the PF1337 sequence and structure. Sequence-structure alignment
with members of the same cluster of orthologous genes (COG; Tatusov et al., 1997) made using
ESPRIPT (Gouet et al., 1999). Strictly conserved and conservatively substituted residues are
colored with a red and yellow background, respectively [according to ESPRIPT using a residue-
similarity Risler matrix; Risler et al., 1988)]. The secondary structure of PF1337 is shown at the top,
with coils representing -helices, and the colored bar indicates relative solvent-accessibility, with
blue indicating accessible, white buried and cyan intermediate. Sequences are labeled with SWISS-
PROT ids or standard genomic open reading frame numbers. Three structure-based sequence
alignments are shown at the bottom, labeled by PDB code. 1q4m is the A. thaliana seed-maturation
protein, a TenA homolog, while 1n45 is human heme oxygenase-1 (Schuller et al., 1999), and 1xik is
the R2 subunit of ribonucleotide reductase from E. coli (Logan et al., 1996). The secondary
structures of 1n45 and 1xik are shown at the bottom.
sharing a common pyrimidine moiety, thereby
raising the possibility of functional hetero-
geneity among TenA homologues. Most
importantly, the many complementary inter-
actions observed at the putative active site in
PF1337 suggest that this protein has high
specificity for HMP-P, consistent with its co-
purification with the protein. The very slow
rate of product release implied by the co-
purification of HMP-P with TenA suggests
that the enzyme will turn over very slowly (at
least in the absence of additional molecular
interactions), and slow enzyme turnover could
explain why it has been difficult to observe
enzymatic activity from the purified protein
(Costello, 1996; Begley et al., 1999).
The co-purification of HMP-P with the
PF1337 protein is probably promoted by the
fact that its binding site is completely solvent-
sequestered (third row in Fig. 3a and Fig. 6b),
meaning that substantial fluctuations in
protein structure would be required for ligand
release. Interestingly, the crystal structure of a
TenA homolog from P. horikoshii (PDB code
1udd) does not show any electron density for
HMP-P in its core, despite showing a 1.7 A˚
r.m.s.d. for the superposition of 202 of 206 C
atoms in PF1337 in residues sharing 27%
sequence identity. The most significant differ-
ence is a 5 A˚ lateral movement of helix 5
relative to helix 9 (Fig. 6a), which results in
solvent exposure of the HMP-P-binding cavity
(Fig. 6b). This movement could allow
substrate binding and product release from
the putative active site in PF1337 and other
TenA homologs.
research papers
596 Benach et al.  TenA homolog Acta Cryst. (2005). D61, 589–598
Figure 5
The putative active site and function of PF1337. (a)
Stereo pair showing the environment of the crystal-
lographically observed HMP-P molecule bound to
PF1337. Residues within a 4 A˚ radius of HMP-P atoms
are shown. The gray electron density is from an
unbiased 2Fo  Fc map calculated prior to the
inclusion of HMP-P in the refinement and contoured
at 1. (b) Stereo pair of the electron density of an
unbiased Fo  Fc map contoured at 1.8. (c)
Schematic plot of the molecular interactions of the
bound HMP-P. Distances are given in angstroms, and
the values in parentheses represent the percentage
identity among the TenA sequences in the COG in the
case of protein residues or B factors in A˚2 in the case
of water molecules. The phosphate moiety of HMP-P
is assumed to be in a protonated state, presumably
reflecting a perturbation in its pKa caused by the
chemical environment in the active site. (d) Reaction
scheme for the biosynthesis of HMP-P from either
HMP or AIR. TenA is hypothesized to catalyze a
similar reaction to ThiC, consistent with the ability of
the tenA gene to genetically complement a thiC
deletion (Morett et al., 2003).
3.5. Implications for the biochemical
function of TenA homologs
The identification of an HMP-P molecule in the phylogen-
etically conserved cavity at the core of PF1337, combined with
the minimal level of sequence conservation on its surface,
strongly supports the hypothesis that TenA homologs play an
enzymatic role in thiamine metabolism. Phosphorylation of
HMP-P yields one of the two basic building blocks of thia-
mine. Based on the current understanding of microbial
thiamine-biosynthesis pathways, there are two different routes
to the synthesis of HMP-P, one involving the phosphorylation
of 4-amino-5-hydroxymethyl-2-methylpyrimidine (HMP) by
the ThiD protein and the other involving a hypothesized
multistep rearrangement of AIR by the ThiC enzyme
(Fig. 5d). The binding of HMP-P to the PF1337 homolog
whose structure is reported in this paper combined with the
previously demonstrated ability of another TenA homolog
to complement a ThiC mutation in vivo suggests that some
homologs may catalyze the same chemical
transformation(s) as ThiC to produce
HMP-P.
However, the exact chemical transfor-
mation performed by ThiC has not been
established because it has not been possible
to demonstrate its activity in purified
enzyme preparations (Costello, 1996). The
hypothesis that ThiC converts AIR to
HMP-P is based on isotopic tracer experi-
ments performed using crude cellular
extracts, which show that the 40, 50 and 20
ribose C atoms of AIR are converted into
the C5, C7 and C8 atoms of the pyrimidine
ring in HMP-P (Cheng et al., 2002; Estra-
mareix & David, 1990; Himmeldirk et al.,
1998; Begley et al., 1999). A complex 11-step
reaction mechanism has been proposed to
explain this remarkable transformation on
ThiC. Because all proposed steps involve
acid–base reactions, such a complex
chemical transformation could conceivably
be performed in the active site of PF1337
and other TenA homologs. While the
volume of the active-site cavity in the
PF1337 structure seems to be too small to
accommodate an AIR molecule, the volume
of the cavity could dynamically expand in
the course of the enzymatic reaction
coupled with specific protein conforma-
tional changes in the course of the enzy-
matic reaction cycle. Moreover, the
complete solvent sequestration of the active
site in PF1337 could be explained by the
need to prevent release of the reactive
chemical fragments that are proposed to be
formed and then recombined in the course
of the proposed 11-step enzyme-bound
transformation.
On the other hand, in the absence of a direct demonstration
of activity by purified enzymes, the exact chemical transfor-
mation performed by ThiC or TenA may be different from the
hypothesized conversion of AIR to HMP-P. Therefore, HMP-
P could conceivably be a substrate for TenA or even an
inhibitor. Moreover, the variable stringency of sequence
conservation at the pyrimidine-binding and phosphate-
binding regions at the active site in PF1337 raises the possi-
bility of functional diversity among TenA homologues. In
conclusion, a variety of questions remain to be answered
concerning the chemical transformations catalyzed by PF1337
and other TenA homologs and their coupling to the dynamic
processes mediating ligand binding and release.
Note added in proof: Toms et al. (2005) have just reported
the structure of TenA from B. subtilis with HMP bound at its
active site, and they also presented data showing that this
enzyme has thiaminase II activity, which cleaves thiamine into
thiazole and HMP. However, this hydrolytic activity does not
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Figure 6
Structural comparison of PF1337 with a P. horikoshii homolog. (a) Stereo pair (Carson, 1987)
showing least-squares alignment of PF1337 (yellow) and PH1161 (blue), with the crystallo-
graphically observed HMP-P molecule in PF1337 shown in magenta CPK representation. (b)
The accessible surfaces of the P. furiosus (left) and P. horikoshii (right) homologs (in the same
orientation as Fig. 6a), with HMP-P shown in magenta CPK representation. HMP-P was
positioned in the putative active site of the P. horikoshii protein based on its alignment with
subunit A of PF1337. The failure to observe the bound HMP-P molecule in PF1337
demonstrates its sequestration from solvent contact.
explain either the ability of the YCR020c TenA homologue
from yeast to complement a thiC deletion (Morett, 2003) or
the co-purification of HMP-P with PF1337 as reported in this
paper. The active site of PF1337 is too small to accommodate
both thiamine and phosphate simultaneously, so it is unlikely
to cleave thiamine using inorganic phosphate. Furthermore,
YCR020c lacks the Cys residue proposed by Toms et al. to
initiate the cleavage of thiamine via nucleophilic attack on the
pyrimidine ring, and the equivalent residue in archaeal TenA
homologues including PF1337 (Cys127) is shifted by one
position in the protein sequence. This shift causes the S atom
of the proposed catalytic residue to be located 9 A˚ away from
the target atom on the pyrimidine ring of HMP-P in the
PF1337 structure, but the pyrimidine ring makes otherwise
equivalent molecular interactions in the PF1337 complex with
HMP-P and the B. subtilis TenA complex with HMP. These
observations suggest that YCR020c and the archaeal TenA
homologues may not have the thiaminase activity observed in
the B. subtilis enzyme. Most strikingly, the phosphate-ligating
residues in PF1337 (Fig. 5c) are conserved in all of the
archaeal TenA homologues that lack the putative catalytic
cysteine at the position observed in B. subtilis TenA, strongly
reinforcing the possibility of functional diversity among TenA
homologues.
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